US Patent Issued to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGYCo., SHANGHAI BAOLONG PHARMACEUTICAL, BAOLONG PHARMACEUTICAL, SHANGHAI BAOLONG ANQING PHARMACEUTICAL on June 23 for "Safe and stable nimodipine formulation for injection and method for preparing same" (Chinese Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,344, issued on June 23, was assigned to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGYCo. LTD. (Shanghai), SHANGHAI BAOLONG PHARMACEUTICAL Co. LTD. (Shanghai), BAOLONG PHARMACEUTICAL Co. LTD. (Bozhou, China) and SHANGHAI BAOLONG ANQING PHARMACEUTICAL Co. LTD. (Anqing, China).

"Safe and stable nimodipine formulation for injection and method for preparing same" was invented by Xin Wu (Shanghai), Youfa Xu (Shanghai), Zhizhe Lin (Shanghai), Yongjie Huang (Shanghai), Jianming Chen (Shanghai), Yuansheng Zhang (Shanghai), Zhiqin Fu (Shanghai), Xinmei Chen (Shanghai) and Hang Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention ...